| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | SUMO ligase activity | 3.40e-10 | 20 | 94 | 6 | GO:0061665 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 1.61e-08 | 36 | 94 | 6 | GO:0019789 | |
| GeneOntologyMolecularFunction | peptidyl-prolyl cis-trans isomerase activity | 1.25e-07 | 50 | 94 | 6 | GO:0003755 | |
| GeneOntologyMolecularFunction | cis-trans isomerase activity | 1.78e-07 | 53 | 94 | 6 | GO:0016859 | |
| GeneOntologyMolecularFunction | isomerase activity | 3.47e-06 | 192 | 94 | 8 | GO:0016853 | |
| GeneOntologyMolecularFunction | GTPase activator activity | 5.18e-05 | 279 | 94 | 8 | GO:0005096 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein ligase activity | 1.08e-04 | 398 | 94 | 9 | GO:0061659 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein transferase activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 MED31 RGPD1 ZNF598 MED12 CDC23 | 1.48e-04 | 512 | 94 | 10 | GO:0019787 |
| GeneOntologyMolecularFunction | aminoacyltransferase activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 MED31 RGPD1 ZNF598 MED12 CDC23 | 2.02e-04 | 532 | 94 | 10 | GO:0016755 |
| GeneOntologyMolecularFunction | ferroxidase activity | 3.25e-04 | 6 | 94 | 2 | GO:0004322 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on metal ions, oxygen as acceptor | 3.25e-04 | 6 | 94 | 2 | GO:0016724 | |
| GeneOntologyMolecularFunction | small GTPase binding | 8.05e-04 | 321 | 94 | 7 | GO:0031267 | |
| GeneOntologyMolecularFunction | enzyme activator activity | RGPD4 RGPD2 RANBP2 RGPD8 STXBP5 RGPD3 RGPD1 TAB1 NLRP3 RGPD5 | 1.03e-03 | 656 | 94 | 10 | GO:0008047 |
| GeneOntologyMolecularFunction | GTPase binding | 1.56e-03 | 360 | 94 | 7 | GO:0051020 | |
| GeneOntologyBiologicalProcess | positive regulation of glucokinase activity | 5.93e-13 | 9 | 93 | 6 | GO:0033133 | |
| GeneOntologyBiologicalProcess | positive regulation of hexokinase activity | 1.48e-12 | 10 | 93 | 6 | GO:1903301 | |
| GeneOntologyBiologicalProcess | NLS-bearing protein import into nucleus | 2.22e-12 | 20 | 93 | 7 | GO:0006607 | |
| GeneOntologyBiologicalProcess | regulation of glucokinase activity | 1.19e-11 | 13 | 93 | 6 | GO:0033131 | |
| GeneOntologyBiologicalProcess | regulation of hexokinase activity | 2.08e-11 | 14 | 93 | 6 | GO:1903299 | |
| GeneOntologyBiologicalProcess | protein peptidyl-prolyl isomerization | 1.75e-08 | 38 | 93 | 6 | GO:0000413 | |
| GeneOntologyBiologicalProcess | hexose biosynthetic process | 5.01e-08 | 115 | 93 | 8 | GO:0019319 | |
| GeneOntologyBiologicalProcess | monosaccharide biosynthetic process | 7.46e-08 | 121 | 93 | 8 | GO:0046364 | |
| GeneOntologyBiologicalProcess | peptidyl-proline modification | 1.55e-07 | 54 | 93 | 6 | GO:0018208 | |
| GeneOntologyBiologicalProcess | gluconeogenesis | 6.99e-07 | 111 | 93 | 7 | GO:0006094 | |
| GeneOntologyBiologicalProcess | regulation of gluconeogenesis | 8.07e-07 | 71 | 93 | 6 | GO:0006111 | |
| GeneOntologyBiologicalProcess | protein folding | 1.70e-06 | 246 | 93 | 9 | GO:0006457 | |
| GeneOntologyBiologicalProcess | carbohydrate biosynthetic process | 1.76e-06 | 247 | 93 | 9 | GO:0016051 | |
| GeneOntologyBiologicalProcess | positive regulation of transferase activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD1 TAB1 SERINC5 MERTK GSK3A AXIN1 AXIN2 | 2.06e-06 | 490 | 93 | 12 | GO:0051347 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate biosynthetic process | 2.25e-06 | 132 | 93 | 7 | GO:0043255 | |
| GeneOntologyBiologicalProcess | regulation of glucose metabolic process | 2.48e-06 | 134 | 93 | 7 | GO:0010906 | |
| GeneOntologyBiologicalProcess | hexose metabolic process | 5.49e-06 | 284 | 93 | 9 | GO:0019318 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphorylation | AKAP6 RGPD4 RGPD2 RANBP2 RGPD8 PTPRJ RGPD3 RGPD1 TAB1 ITLN2 MERTK GSK3A AXIN1 AXIN2 | 1.01e-05 | 780 | 93 | 14 | GO:0042327 |
| GeneOntologyBiologicalProcess | monosaccharide metabolic process | 1.11e-05 | 310 | 93 | 9 | GO:0005996 | |
| GeneOntologyBiologicalProcess | positive regulation of kinase activity | 1.44e-05 | 405 | 93 | 10 | GO:0033674 | |
| GeneOntologyBiologicalProcess | glucose metabolic process | 1.47e-05 | 244 | 93 | 8 | GO:0006006 | |
| GeneOntologyBiologicalProcess | protein import into nucleus | 2.89e-05 | 195 | 93 | 7 | GO:0006606 | |
| GeneOntologyBiologicalProcess | import into nucleus | 3.51e-05 | 201 | 93 | 7 | GO:0051170 | |
| GeneOntologyBiologicalProcess | positive regulation of phosphate metabolic process | AKAP6 RGPD4 RGPD2 RANBP2 RGPD8 PTPRJ RGPD3 RGPD1 TAB1 ITLN2 MERTK GSK3A AXIN1 AXIN2 | 3.80e-05 | 879 | 93 | 14 | GO:0045937 |
| GeneOntologyBiologicalProcess | positive regulation of phosphorus metabolic process | AKAP6 RGPD4 RGPD2 RANBP2 RGPD8 PTPRJ RGPD3 RGPD1 TAB1 ITLN2 MERTK GSK3A AXIN1 AXIN2 | 3.80e-05 | 879 | 93 | 14 | GO:0010562 |
| GeneOntologyBiologicalProcess | mRNA transport | 5.02e-05 | 145 | 93 | 6 | GO:0051028 | |
| GeneOntologyBiologicalProcess | small molecule biosynthetic process | RGPD4 RGPD2 RANBP2 GNPDA1 RGPD8 MTHFR RGPD3 RGPD1 LTA4H FBP2 SERINC5 PDXK | 5.13e-05 | 676 | 93 | 12 | GO:0044283 |
| GeneOntologyBiologicalProcess | regulation of transferase activity | RGPD4 RGPD2 RANBP2 RGPD8 PTPRJ RGPD3 RGPD1 TAB1 SERINC5 MERTK GSK3A AXIN1 AXIN2 | 6.84e-05 | 810 | 93 | 13 | GO:0051338 |
| GeneOntologyBiologicalProcess | regulation of carbohydrate metabolic process | 8.44e-05 | 231 | 93 | 7 | GO:0006109 | |
| GeneOntologyBiologicalProcess | protein maturation | RGPD4 RGPD2 RANBP2 HSP90B2P RGPD8 RGPD3 RGPD1 TOR1A TTC4 NLRP3 SORL1 | 1.07e-04 | 619 | 93 | 11 | GO:0051604 |
| GeneOntologyBiologicalProcess | establishment of protein localization to organelle | RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 VPS13A RGPD1 GSK3A SORL1 RGPD5 | 1.09e-04 | 515 | 93 | 10 | GO:0072594 |
| GeneOntologyBiologicalProcess | RNA transport | 1.42e-04 | 175 | 93 | 6 | GO:0050658 | |
| GeneOntologyBiologicalProcess | nucleic acid transport | 1.42e-04 | 175 | 93 | 6 | GO:0050657 | |
| GeneOntologyBiologicalProcess | sarcomere organization | 1.46e-04 | 59 | 93 | 4 | GO:0045214 | |
| GeneOntologyBiologicalProcess | carbohydrate metabolic process | RGPD4 RGPD2 RANBP2 GNPDA1 RGPD8 MLEC RGPD3 RGPD1 PYGL FBP2 GSK3A | 1.55e-04 | 646 | 93 | 11 | GO:0005975 |
| GeneOntologyBiologicalProcess | establishment of RNA localization | 1.55e-04 | 178 | 93 | 6 | GO:0051236 | |
| GeneOntologyBiologicalProcess | nuclear export | 1.92e-04 | 185 | 93 | 6 | GO:0051168 | |
| GeneOntologyBiologicalProcess | protein retention in Golgi apparatus | 1.99e-04 | 5 | 93 | 2 | GO:0045053 | |
| GeneOntologyBiologicalProcess | post-Golgi vesicle-mediated transport | 2.04e-04 | 119 | 93 | 5 | GO:0006892 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell development | 2.29e-04 | 122 | 93 | 5 | GO:0055013 | |
| GeneOntologyBiologicalProcess | protein localization to nucleus | 2.32e-04 | 362 | 93 | 8 | GO:0034504 | |
| GeneOntologyBiologicalProcess | regulation of kinase activity | RGPD4 RGPD2 RANBP2 RGPD8 PTPRJ RGPD3 RGPD1 TAB1 MERTK AXIN1 AXIN2 | 2.61e-04 | 686 | 93 | 11 | GO:0043549 |
| GeneOntologyBiologicalProcess | nuclear transport | 3.10e-04 | 378 | 93 | 8 | GO:0051169 | |
| GeneOntologyBiologicalProcess | nucleocytoplasmic transport | 3.10e-04 | 378 | 93 | 8 | GO:0006913 | |
| GeneOntologyBiologicalProcess | cardiac cell development | 3.29e-04 | 132 | 93 | 5 | GO:0055006 | |
| GeneOntologyBiologicalProcess | RNA localization | 4.51e-04 | 217 | 93 | 6 | GO:0006403 | |
| GeneOntologyBiologicalProcess | contact inhibition | 5.53e-04 | 8 | 93 | 2 | GO:0060242 | |
| GeneOntologyBiologicalProcess | atrial cardiac muscle tissue morphogenesis | 5.53e-04 | 8 | 93 | 2 | GO:0055009 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 5.67e-04 | 84 | 93 | 4 | GO:1903053 | |
| GeneOntologyBiologicalProcess | myofibril assembly | 6.20e-04 | 86 | 93 | 4 | GO:0030239 | |
| GeneOntologyBiologicalProcess | positive regulation of catalytic activity | RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD1 TAB1 SERINC5 MERTK GSK3A NLRP3 AXIN1 AXIN2 | 6.94e-04 | 1028 | 93 | 13 | GO:0043085 |
| GeneOntologyBiologicalProcess | striated muscle cell development | 7.06e-04 | 89 | 93 | 4 | GO:0055002 | |
| GeneOntologyBiologicalProcess | cellular anatomical entity morphogenesis | 7.06e-04 | 156 | 93 | 5 | GO:0032989 | |
| GeneOntologyBiologicalProcess | cellular component assembly involved in morphogenesis | 7.06e-04 | 156 | 93 | 5 | GO:0010927 | |
| GeneOntologyBiologicalProcess | detection of cell density | 7.09e-04 | 9 | 93 | 2 | GO:0060245 | |
| GeneOntologyBiologicalProcess | nucleobase-containing compound transport | 9.25e-04 | 249 | 93 | 6 | GO:0015931 | |
| GeneOntologyBiologicalProcess | cardiac muscle contraction | 9.59e-04 | 167 | 93 | 5 | GO:0060048 | |
| GeneOntologyBiologicalProcess | proteasomal protein catabolic process | 1.04e-03 | 567 | 93 | 9 | GO:0010498 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.08e-03 | 11 | 93 | 2 | GO:0110011 | |
| GeneOntologyBiologicalProcess | muscle cell development | 1.13e-03 | 259 | 93 | 6 | GO:0055001 | |
| GeneOntologyBiologicalProcess | regulation of phosphorylation | AKAP6 RGPD4 RGPD2 RANBP2 RGPD8 PTPRJ RGPD3 RGPD1 TAB1 ITLN2 MERTK GSK3A AXIN1 AXIN2 | 1.15e-03 | 1226 | 93 | 14 | GO:0042325 |
| GeneOntologyBiologicalProcess | detection of biotic stimulus | 1.17e-03 | 46 | 93 | 3 | GO:0009595 | |
| GeneOntologyBiologicalProcess | cardiac muscle cell differentiation | 1.24e-03 | 177 | 93 | 5 | GO:0055007 | |
| GeneOntologyCellularComponent | cytoplasmic periphery of the nuclear pore complex | 2.09e-13 | 8 | 95 | 6 | GO:1990723 | |
| GeneOntologyCellularComponent | nuclear pore cytoplasmic filaments | 1.55e-12 | 10 | 95 | 6 | GO:0044614 | |
| GeneOntologyCellularComponent | annulate lamellae | 2.19e-11 | 14 | 95 | 6 | GO:0005642 | |
| GeneOntologyCellularComponent | nuclear pore nuclear basket | 1.33e-10 | 18 | 95 | 6 | GO:0044615 | |
| GeneOntologyCellularComponent | nuclear inclusion body | 2.76e-10 | 20 | 95 | 6 | GO:0042405 | |
| GeneOntologyCellularComponent | SUMO ligase complex | 3.86e-10 | 21 | 95 | 6 | GO:0106068 | |
| GeneOntologyCellularComponent | nuclear pore | 3.89e-07 | 101 | 95 | 7 | GO:0005643 | |
| GeneOntologyCellularComponent | nuclear membrane | AKAP6 RGPD4 RGPD2 RANBP2 BRIP1 RGPD8 CENPF RGPD3 RGPD1 TOR1A AK9 | 5.37e-07 | 349 | 95 | 11 | GO:0031965 |
| GeneOntologyCellularComponent | nuclear envelope | AKAP6 RGPD4 RGPD2 RANBP2 BRIP1 RGPD8 CENPF RGPD3 RGPD1 TOR1A AK9 SORL1 RGPD5 | 1.49e-06 | 560 | 95 | 13 | GO:0005635 |
| GeneOntologyCellularComponent | inclusion body | 3.44e-06 | 90 | 95 | 6 | GO:0016234 | |
| GeneOntologyCellularComponent | nuclear outer membrane-endoplasmic reticulum membrane network | AKAP6 RGPD4 RGPD2 NBAS RANBP2 HSP90B2P REEP1 RGPD8 MLEC DNAJC16 RGPD3 VPS13A RGPD1 TOR1A CASQ2 TAB1 SEL1L2 GABBR1 SORL1 | 6.88e-06 | 1327 | 95 | 19 | GO:0042175 |
| GeneOntologyCellularComponent | perinuclear region of cytoplasm | AKAP6 RGPD4 RGPD2 RANBP2 HSP90B2P RGPD8 CENPF STK26 RGPD3 RGPD1 EXOC1 SERINC5 HEPH AXIN1 SORL1 | 1.96e-05 | 934 | 95 | 15 | GO:0048471 |
| GeneOntologyCellularComponent | beta-catenin destruction complex | 2.52e-05 | 13 | 95 | 3 | GO:0030877 | |
| GeneOntologyCellularComponent | organelle envelope | AKAP6 RGPD4 RGPD2 RANBP2 HSP90B2P BRIP1 REEP1 RGPD8 CENPF RGPD3 VPS13A RGPD1 TOR1A AK9 GABBR1 SORL1 RGPD5 | 2.33e-04 | 1435 | 95 | 17 | GO:0031967 |
| GeneOntologyCellularComponent | Z disc | 6.32e-04 | 151 | 95 | 5 | GO:0030018 | |
| GeneOntologyCellularComponent | junctional sarcoplasmic reticulum membrane | 8.98e-04 | 10 | 95 | 2 | GO:0014701 | |
| GeneOntologyCellularComponent | I band | 9.69e-04 | 166 | 95 | 5 | GO:0031674 | |
| GeneOntologyCellularComponent | myofibril | 1.55e-03 | 273 | 95 | 6 | GO:0030016 | |
| GeneOntologyCellularComponent | contractile muscle fiber | 2.10e-03 | 290 | 95 | 6 | GO:0043292 | |
| MousePheno | abnormal morula morphology | 1.16e-12 | 26 | 80 | 8 | MP:0012058 | |
| MousePheno | elevated level of mitotic sister chromatid exchange | 2.22e-10 | 16 | 80 | 6 | MP:0003701 | |
| MousePheno | decreased tumor latency | 1.55e-08 | 30 | 80 | 6 | MP:0010308 | |
| MousePheno | failure of blastocyst formation | 1.91e-08 | 31 | 80 | 6 | MP:0012129 | |
| MousePheno | abnormal tumor latency | 3.44e-08 | 34 | 80 | 6 | MP:0010307 | |
| MousePheno | abnormal blastocyst formation | 8.15e-08 | 39 | 80 | 6 | MP:0012128 | |
| MousePheno | aneuploidy | 1.26e-06 | 61 | 80 | 6 | MP:0004024 | |
| MousePheno | embryonic lethality before implantation, complete penetrance | 2.29e-06 | 203 | 80 | 9 | MP:0011094 | |
| MousePheno | failure of blastocyst to hatch from the zona pellucida | 2.54e-06 | 107 | 80 | 7 | MP:0003694 | |
| MousePheno | increased hepatocellular carcinoma incidence | 2.85e-06 | 70 | 80 | 6 | MP:0003331 | |
| MousePheno | abnormal blastocyst hatching | 3.65e-06 | 113 | 80 | 7 | MP:0003693 | |
| MousePheno | abnormal rod electrophysiology | 5.16e-06 | 119 | 80 | 7 | MP:0004021 | |
| MousePheno | increased lung carcinoma incidence | 5.38e-06 | 78 | 80 | 6 | MP:0008714 | |
| MousePheno | abnormal gait | SLC6A2 BRIP1 REEP1 STXBP5 SLC26A4 VPS13A TOR1A CP NEB PREPL GSK3A GABBR1 SORL1 | 7.22e-06 | 520 | 80 | 13 | MP:0001406 |
| MousePheno | abnormal chromosome morphology | 7.53e-06 | 126 | 80 | 7 | MP:0003702 | |
| MousePheno | abnormal chromosome number | 9.49e-06 | 86 | 80 | 6 | MP:0004023 | |
| MousePheno | embryonic lethality before implantation | 9.58e-06 | 242 | 80 | 9 | MP:0006204 | |
| MousePheno | abnormal cell nucleus morphology | 9.99e-06 | 184 | 80 | 8 | MP:0003111 | |
| MousePheno | enlarged epididymis | 2.13e-05 | 99 | 80 | 6 | MP:0004931 | |
| MousePheno | increased sarcoma incidence | 2.53e-05 | 102 | 80 | 6 | MP:0002032 | |
| MousePheno | increased respiratory system tumor incidence | 3.32e-05 | 107 | 80 | 6 | MP:0010298 | |
| MousePheno | increased lung tumor incidence | 3.32e-05 | 107 | 80 | 6 | MP:0008014 | |
| MousePheno | abnormal preimplantation embryo morphology | 3.32e-05 | 283 | 80 | 9 | MP:0014137 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 3.60e-05 | 286 | 80 | 9 | MP:0008873 | |
| MousePheno | increased hepatobiliary system tumor incidence | 4.08e-05 | 111 | 80 | 6 | MP:0010297 | |
| MousePheno | increased liver tumor incidence | 4.08e-05 | 111 | 80 | 6 | MP:0008019 | |
| MousePheno | abnormal eye electrophysiology | 4.68e-05 | 228 | 80 | 8 | MP:0005551 | |
| MousePheno | abnormal preimplantation embryo development | 5.44e-05 | 171 | 80 | 7 | MP:0009781 | |
| MousePheno | abnormal mitosis | 9.05e-05 | 128 | 80 | 6 | MP:0004046 | |
| MousePheno | increased carcinoma incidence | 1.32e-04 | 197 | 80 | 7 | MP:0002038 | |
| MousePheno | increased incidence of tumors by chemical induction | 1.54e-04 | 141 | 80 | 6 | MP:0004499 | |
| MousePheno | abnormal locomotor coordination | SLC6A2 BRIP1 REEP1 STXBP5 SLC26A4 VPS13A TOR1A CP NEB PREPL GSK3A GABBR1 SORL1 | 2.25e-04 | 726 | 80 | 13 | MP:0003312 |
| MousePheno | decreased susceptibility to diet-induced obesity | 3.06e-04 | 160 | 80 | 6 | MP:0005659 | |
| MousePheno | abnormal epididymis size | 3.73e-04 | 166 | 80 | 6 | MP:0004926 | |
| MousePheno | increased malignant tumor incidence | 4.09e-04 | 237 | 80 | 7 | MP:0002018 | |
| MousePheno | increased incidence of induced tumors | 4.64e-04 | 173 | 80 | 6 | MP:0002021 | |
| MousePheno | abnormal embryo development | RGPD4 RGPD2 RANBP2 HSP90B2P GNPDA1 RGPD8 PTPRJ BMP10 POLR2B RGPD3 MED31 LAMA1 RGPD1 UTP3 TTC4 MED12 AXIN1 AXIN2 | 6.04e-04 | 1370 | 80 | 18 | MP:0001672 |
| MousePheno | decreased susceptibility to weight gain | 6.80e-04 | 186 | 80 | 6 | MP:0010182 | |
| MousePheno | abnormal incidence of induced tumors | 8.67e-04 | 269 | 80 | 7 | MP:0013151 | |
| MousePheno | abnormal epididymis morphology | 8.67e-04 | 269 | 80 | 7 | MP:0002631 | |
| MousePheno | increased energy expenditure | 8.94e-04 | 196 | 80 | 6 | MP:0004889 | |
| MousePheno | abnormal intracellular organelle morphology | RGPD4 RGPD2 RANBP2 BRIP1 REEP1 RGPD8 RGPD3 VPS13A RGPD1 TOR1A | 1.07e-03 | 546 | 80 | 10 | MP:0014239 |
| Domain | Ran_BP1 | 4.68e-14 | 12 | 93 | 7 | PF00638 | |
| Domain | RANBD1 | 4.68e-14 | 12 | 93 | 7 | PS50196 | |
| Domain | RanBD | 1.01e-13 | 13 | 93 | 7 | SM00160 | |
| Domain | Ran_bind_dom | 1.01e-13 | 13 | 93 | 7 | IPR000156 | |
| Domain | Grip | 5.86e-12 | 11 | 93 | 6 | SM00755 | |
| Domain | GRIP | 5.86e-12 | 11 | 93 | 6 | PF01465 | |
| Domain | TPR-contain_dom | WDR19 RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 VPS13A RGPD1 STIP1 TTC4 CDC23 RGPD5 | 1.10e-11 | 150 | 93 | 12 | IPR013026 |
| Domain | GRIP_dom | 1.17e-11 | 12 | 93 | 6 | IPR000237 | |
| Domain | GRIP | 1.17e-11 | 12 | 93 | 6 | PS50913 | |
| Domain | TPR_REGION | WDR19 RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 VPS13A RGPD1 STIP1 TTC4 CDC23 RGPD5 | 3.39e-11 | 165 | 93 | 12 | PS50293 |
| Domain | TPR | WDR19 RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 VPS13A RGPD1 STIP1 TTC4 CDC23 RGPD5 | 3.39e-11 | 165 | 93 | 12 | PS50005 |
| Domain | GCC2_Rab_bind | 5.72e-11 | 7 | 93 | 5 | IPR032023 | |
| Domain | Rab_bind | 5.72e-11 | 7 | 93 | 5 | PF16704 | |
| Domain | - | 6.78e-10 | 10 | 93 | 5 | 1.10.220.60 | |
| Domain | TPR-like_helical_dom | WDR19 RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD1 STIP1 SEL1L2 TTC4 CDC23 RGPD5 | 1.83e-09 | 233 | 93 | 12 | IPR011990 |
| Domain | - | WDR19 RGPD4 RGPD2 RANBP2 RGPD8 RGPD3 RGPD1 STIP1 SEL1L2 TTC4 CDC23 | 6.55e-09 | 207 | 93 | 11 | 1.25.40.10 |
| Domain | TPR | 1.59e-08 | 129 | 93 | 9 | SM00028 | |
| Domain | TPR_repeat | 2.08e-08 | 133 | 93 | 9 | IPR019734 | |
| Domain | TPR_1 | 3.22e-07 | 90 | 93 | 7 | PF00515 | |
| Domain | TPR_1 | 3.22e-07 | 90 | 93 | 7 | IPR001440 | |
| Domain | Axin_b-cat-bd | 2.45e-05 | 2 | 93 | 2 | IPR014936 | |
| Domain | Axin_TNKS-bd | 2.45e-05 | 2 | 93 | 2 | IPR032101 | |
| Domain | AXIN1_TNKS_BD | 2.45e-05 | 2 | 93 | 2 | PF16646 | |
| Domain | Axin_b-cat_bind | 2.45e-05 | 2 | 93 | 2 | PF08833 | |
| Domain | PH_dom-like | RGPD4 RGPD2 FRMD4A RANBP2 RGPD8 RGPD3 RGPD1 PLEKHD1 PHLDB2 RGPD5 | 5.13e-05 | 426 | 93 | 10 | IPR011993 |
| Domain | MULTICOPPER_OXIDASE2 | 7.33e-05 | 3 | 93 | 2 | PS00080 | |
| Domain | Cu-oxidase | 7.33e-05 | 3 | 93 | 2 | PF00394 | |
| Domain | Cu-oxidase | 7.33e-05 | 3 | 93 | 2 | IPR001117 | |
| Domain | - | 1.44e-04 | 391 | 93 | 9 | 2.30.29.30 | |
| Domain | Cu-oxidase_2 | 1.46e-04 | 4 | 93 | 2 | IPR011706 | |
| Domain | Cu-oxidase_2 | 1.46e-04 | 4 | 93 | 2 | PF07731 | |
| Domain | Cu_oxidase_CS | 2.43e-04 | 5 | 93 | 2 | IPR033138 | |
| Domain | PRO_ENDOPEP_SER | 2.43e-04 | 5 | 93 | 2 | PS00708 | |
| Domain | Cu-oxidase_3 | 2.43e-04 | 5 | 93 | 2 | IPR011707 | |
| Domain | MULTICOPPER_OXIDASE1 | 2.43e-04 | 5 | 93 | 2 | PS00079 | |
| Domain | Cu-oxidase_3 | 2.43e-04 | 5 | 93 | 2 | PF07732 | |
| Domain | Cu_oxidase_Cu_BS | 3.63e-04 | 6 | 93 | 2 | IPR002355 | |
| Domain | Haem_d1 | 3.63e-04 | 6 | 93 | 2 | IPR011048 | |
| Domain | TPR_11 | 5.07e-04 | 7 | 93 | 2 | PF13414 | |
| Domain | DIX | 5.07e-04 | 7 | 93 | 2 | PF00778 | |
| Domain | DIX | 5.07e-04 | 7 | 93 | 2 | IPR001158 | |
| Domain | DIX | 5.07e-04 | 7 | 93 | 2 | PS50841 | |
| Domain | DAX | 5.07e-04 | 7 | 93 | 2 | SM00021 | |
| Domain | Peptidase_S9 | 1.31e-03 | 11 | 93 | 2 | PF00326 | |
| Domain | Peptidase_S9 | 1.31e-03 | 11 | 93 | 2 | IPR001375 | |
| Domain | - | 2.15e-03 | 14 | 93 | 2 | 2.60.40.420 | |
| Pathway | BIOCARTA_RANBP2_PATHWAY | 3.54e-10 | 18 | 76 | 6 | MM1549 | |
| Pathway | REACTOME_GLUCOSE_METABOLISM | 1.27e-08 | 82 | 76 | 8 | MM15394 | |
| Pathway | REACTOME_NUCLEAR_PORE_COMPLEX_NPC_DISASSEMBLY | 6.67e-08 | 40 | 76 | 6 | MM14945 | |
| Pathway | REACTOME_TRANSCRIPTIONAL_REGULATION_BY_SMALL_RNAS | 7.78e-08 | 41 | 76 | 6 | MM15200 | |
| Pathway | REACTOME_SUMOYLATION_OF_SUMOYLATION_PROTEINS | 9.03e-08 | 42 | 76 | 6 | MM15039 | |
| Pathway | REACTOME_TRANSPORT_OF_THE_SLBP_DEPENDANT_MATURE_MRNA | 1.05e-07 | 43 | 76 | 6 | MM14609 | |
| Pathway | REACTOME_SUMOYLATION_OF_UBIQUITINYLATION_PROTEINS | 1.81e-07 | 47 | 76 | 6 | MM14939 | |
| Pathway | REACTOME_MITOTIC_SPINDLE_CHECKPOINT | 2.08e-07 | 117 | 76 | 8 | MM15387 | |
| Pathway | REACTOME_GENE_SILENCING_BY_RNA | 2.34e-07 | 49 | 76 | 6 | MM14837 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_MRNAS_DERIVED_FROM_INTRONLESS_TRANSCRIPTS | 2.64e-07 | 50 | 76 | 6 | MM14610 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_REPLICATION_PROTEINS | 2.98e-07 | 51 | 76 | 6 | MM15151 | |
| Pathway | REACTOME_NUCLEAR_ENVELOPE_BREAKDOWN | 4.72e-07 | 55 | 76 | 6 | MM14917 | |
| Pathway | REACTOME_SUMOYLATION_OF_RNA_BINDING_PROTEINS | 6.51e-07 | 58 | 76 | 6 | MM15149 | |
| Pathway | REACTOME_SNRNP_ASSEMBLY | 6.51e-07 | 58 | 76 | 6 | MM14736 | |
| Pathway | REACTOME_SEPARATION_OF_SISTER_CHROMATIDS | 9.06e-07 | 193 | 76 | 9 | MM14890 | |
| Pathway | REACTOME_AMPLIFICATION_OF_SIGNAL_FROM_THE_KINETOCHORES | 1.07e-06 | 100 | 76 | 7 | MM14561 | |
| Pathway | REACTOME_SUMOYLATION_OF_CHROMATIN_ORGANIZATION_PROTEINS | 1.29e-06 | 65 | 76 | 6 | MM15147 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | RGPD4 RGPD2 RANBP2 BRIP1 RGPD8 CENPF RGPD3 RGPD1 PSMD2 CDC23 | 1.82e-06 | 271 | 76 | 10 | MM15388 |
| Pathway | REACTOME_REGULATION_OF_HSF1_MEDIATED_HEAT_SHOCK_RESPONSE | 2.57e-06 | 73 | 76 | 6 | MM14948 | |
| Pathway | REACTOME_MITOTIC_METAPHASE_AND_ANAPHASE | 4.45e-06 | 234 | 76 | 9 | MM14898 | |
| Pathway | REACTOME_SUMOYLATION_OF_DNA_DAMAGE_RESPONSE_AND_REPAIR_PROTEINS | 5.85e-06 | 84 | 76 | 6 | MM14929 | |
| Pathway | REACTOME_RESOLUTION_OF_SISTER_CHROMATID_COHESION | 5.91e-06 | 129 | 76 | 7 | MM14894 | |
| Pathway | REACTOME_TRANSPORT_OF_MATURE_TRANSCRIPT_TO_CYTOPLASM | 6.71e-06 | 86 | 76 | 6 | MM15413 | |
| Pathway | REACTOME_CELLULAR_RESPONSE_TO_HEAT_STRESS | 9.92e-06 | 92 | 76 | 6 | MM14951 | |
| Pathway | REACTOME_RHO_GTPASES_ACTIVATE_FORMINS | 1.06e-05 | 141 | 76 | 7 | MM15266 | |
| Pathway | REACTOME_METABOLISM_OF_CARBOHYDRATES | 1.45e-05 | 271 | 76 | 9 | MM15406 | |
| Pathway | REACTOME_MITOTIC_PROPHASE | 3.38e-05 | 114 | 76 | 6 | MM15361 | |
| Pathway | REACTOME_MITOTIC_PROMETAPHASE | 1.06e-04 | 202 | 76 | 7 | MM15362 | |
| Pathway | PID_BETA_CATENIN_DEG_PATHWAY | 1.16e-04 | 18 | 76 | 3 | M31 | |
| Pathway | REACTOME_SLC_TRANSPORTER_DISORDERS | 1.92e-04 | 99 | 76 | 5 | M27474 | |
| Pathway | REACTOME_M_PHASE | 2.26e-04 | 387 | 76 | 9 | MM15364 | |
| Pathway | REACTOME_SUMOYLATION | 2.97e-04 | 169 | 76 | 6 | MM14919 | |
| Pathway | REACTOME_CELLULAR_RESPONSES_TO_STIMULI | 3.64e-04 | 505 | 76 | 10 | MM15548 | |
| Pathway | REACTOME_DISORDERS_OF_TRANSMEMBRANE_TRANSPORTERS | 3.80e-04 | 177 | 76 | 6 | M27476 | |
| Pathway | REACTOME_RHO_GTPASE_EFFECTORS | 4.62e-04 | 257 | 76 | 7 | MM14755 | |
| Pathway | REACTOME_PROCESSING_OF_CAPPED_INTRON_CONTAINING_PRE_MRNA | 7.21e-04 | 277 | 76 | 7 | MM15414 | |
| Pathway | REACTOME_CELL_CYCLE | RGPD4 RGPD2 RANBP2 BRIP1 RGPD8 CENPF RGPD3 RGPD1 PSMD2 CDC23 | 1.42e-03 | 603 | 76 | 10 | MM14635 |
| Pathway | REACTOME_METABOLISM_OF_RNA | 1.59e-03 | 612 | 76 | 10 | MM15547 | |
| Pathway | KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_APC_TO_WNT_SIGNALING_PATHWAY | 1.83e-03 | 12 | 76 | 2 | M47410 | |
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 9037092 | ||
| Pubmed | Complex genomic rearrangements lead to novel primate gene function. | 2.47e-15 | 7 | 95 | 6 | 15710750 | |
| Pubmed | Genomic organization, expression, and localization of murine Ran-binding protein 2 (RanBP2) gene. | 2.47e-15 | 7 | 95 | 6 | 11353387 | |
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 30944974 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 38838144 | ||
| Pubmed | Retina-specifically expressed novel subtypes of bovine cyclophilin. | 2.47e-15 | 7 | 95 | 6 | 7559465 | |
| Pubmed | Mst1, RanBP2 and eIF4G are new markers for in vivo PI3K activation in murine and human prostate. | 2.47e-15 | 7 | 95 | 6 | 17372272 | |
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 38657106 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 21205196 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 18949001 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 25187515 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 8603673 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 26632511 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 24403063 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 23818861 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 23536549 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 12191015 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 22821000 | ||
| Pubmed | 2.47e-15 | 7 | 95 | 6 | 20682751 | ||
| Pubmed | 5.72e-15 | 15 | 95 | 7 | 14697343 | ||
| Pubmed | The nucleoporin RanBP2 tethers the cAMP effector Epac1 and inhibits its catalytic activity. | 9.86e-15 | 8 | 95 | 6 | 21670213 | |
| Pubmed | 9.86e-15 | 8 | 95 | 6 | 27412403 | ||
| Pubmed | Mice lacking Ran binding protein 1 are viable and show male infertility. | 9.86e-15 | 8 | 95 | 6 | 21310149 | |
| Pubmed | The distribution of phosphorylated SR proteins and alternative splicing are regulated by RANBP2. | 9.86e-15 | 8 | 95 | 6 | 22262462 | |
| Pubmed | Zap70 and downstream RanBP2 are required for the exact timing of the meiotic cell cycle in oocytes. | 9.86e-15 | 8 | 95 | 6 | 28745977 | |
| Pubmed | Resolution of sister centromeres requires RanBP2-mediated SUMOylation of topoisomerase IIalpha. | 2.95e-14 | 9 | 95 | 6 | 18394993 | |
| Pubmed | 2.95e-14 | 9 | 95 | 6 | 28100513 | ||
| Pubmed | 2.95e-14 | 9 | 95 | 6 | 17887960 | ||
| Pubmed | 2.95e-14 | 9 | 95 | 6 | 11553612 | ||
| Pubmed | 2.95e-14 | 9 | 95 | 6 | 10601307 | ||
| Pubmed | 2.95e-14 | 9 | 95 | 6 | 9733766 | ||
| Pubmed | 2.95e-14 | 9 | 95 | 6 | 28877029 | ||
| Pubmed | 7.36e-14 | 10 | 95 | 6 | 27160050 | ||
| Pubmed | Parkin ubiquitinates and promotes the degradation of RanBP2. | 7.36e-14 | 10 | 95 | 6 | 16332688 | |
| Pubmed | Cyclophilin-related protein RanBP2 acts as chaperone for red/green opsin. | 7.36e-14 | 10 | 95 | 6 | 8857542 | |
| Pubmed | 7.36e-14 | 10 | 95 | 6 | 21859863 | ||
| Pubmed | 1.62e-13 | 11 | 95 | 6 | 17069463 | ||
| Pubmed | An Rtn4/Nogo-A-interacting micropeptide modulates synaptic plasticity with age. | 1.62e-13 | 11 | 95 | 6 | 35771867 | |
| Pubmed | 1.62e-13 | 11 | 95 | 6 | 34110283 | ||
| Pubmed | Ankyrin-G induces nucleoporin Nup358 to associate with the axon initial segment of neurons. | 5.98e-13 | 13 | 95 | 6 | 31427429 | |
| Pubmed | 2.55e-11 | 22 | 95 | 6 | 27717094 | ||
| Pubmed | RGPD4 RGPD2 FRMD4A RANBP2 HSP90B2P REEP1 RGPD8 MLEC DNAJC16 RGPD3 PDE4DIP RGPD1 PSMD2 EXOC1 STIP1 TAB1 GSK3A GABBR1 PDXK | 2.27e-10 | 1139 | 95 | 19 | 36417873 | |
| Pubmed | Peering through the pore: nuclear pore complex structure, assembly, and function. | 9.10e-10 | 38 | 95 | 6 | 12791264 | |
| Pubmed | The protein interaction landscape of the human CMGC kinase group. | RANBP2 STK26 POLR2B MED31 LAMA1 STIP1 NEB EDIL3 NOP2 MED12 GSK3A AXIN1 AXIN2 SORL1 | 6.55e-09 | 695 | 95 | 14 | 23602568 |
| Pubmed | RGPD4 RGPD2 RANBP2 MYH6 RGPD8 MLEC RGPD3 RGPD1 PSMD2 PYGL STIP1 TAB1 NEB NOP2 RGPD5 | 9.59e-09 | 844 | 95 | 15 | 25963833 | |
| Pubmed | Systematic identification of factors for provirus silencing in embryonic stem cells. | 1.03e-08 | 153 | 95 | 8 | 26365490 | |
| Pubmed | 1.10e-08 | 99 | 95 | 7 | 27746211 | ||
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | RGPD4 RGPD2 RANBP2 RGPD8 MLEC STK26 POLR2B RGPD3 RGPD1 PSMD2 PYGL TTC4 NOP2 MED12 PDXK CDC23 RGPD5 | 4.93e-08 | 1257 | 95 | 17 | 37317656 |
| Pubmed | 7.88e-08 | 4 | 95 | 3 | 9480752 | ||
| Pubmed | 1.40e-07 | 86 | 95 | 6 | 37253089 | ||
| Pubmed | 1.43e-07 | 215 | 95 | 8 | 35973513 | ||
| Pubmed | A direct physical interaction between Nanog and Sox2 regulates embryonic stem cell self-renewal. | 1.61e-07 | 146 | 95 | 7 | 23892456 | |
| Pubmed | Generation and annotation of the DNA sequences of human chromosomes 2 and 4. | RGPD4 RGPD2 RANBP2 UBTFL6 REEP1 BMP10 RGPD3 RGPD1 ZC3H6 RGPD5 | 3.83e-07 | 442 | 95 | 10 | 15815621 |
| Pubmed | Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling. | 3.93e-07 | 6 | 95 | 3 | 19759537 | |
| Pubmed | Systematic analysis of human protein complexes identifies chromosome segregation proteins. | RGPD4 RGPD2 NBAS RANBP2 RGPD8 CENPF STK26 RGPD3 RGPD1 PROSER1 EDIL3 NOP2 CDC23 RGPD5 RAVER1 | 5.54e-07 | 1155 | 95 | 15 | 20360068 |
| Pubmed | 1.64e-06 | 9 | 95 | 3 | 9601641 | ||
| Pubmed | Interaction of Sox2 with RNA binding proteins in mouse embryonic stem cells. | 2.00e-06 | 135 | 95 | 6 | 31077711 | |
| Pubmed | 2.27e-06 | 418 | 95 | 9 | 34709266 | ||
| Pubmed | Gsk3β is required in the epithelium for palatal elevation in mice. | 2.34e-06 | 10 | 95 | 3 | 20981831 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | RANBP2 HSP90B2P MLEC DNAJC16 ANXA3 PSMD2 PYGL STIP1 TAB1 ZNF598 NOP2 PREPL SORL1 | 2.52e-06 | 974 | 95 | 13 | 28675297 |
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | NBAS RGPD8 CENPF POLR2B VPS13A PSMD2 PROSER1 STIP1 TAB1 UTP3 ZNF598 TTC4 NOP2 PREPL CDC23 RAVER1 | 2.82e-06 | 1496 | 95 | 16 | 32877691 |
| Pubmed | Proteomic and yeast 2-hybrid screens to identify PTEN binding partners. | 3.03e-06 | 226 | 95 | 7 | 37839992 | |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 3.50e-06 | 231 | 95 | 7 | 16452087 | |
| Pubmed | Scanning the human proteome for calmodulin-binding proteins. | 5.57e-06 | 92 | 95 | 5 | 15840729 | |
| Pubmed | Beta-catenin is temporally regulated during normal liver development. | 7.03e-06 | 14 | 95 | 3 | 15057752 | |
| Pubmed | RANBP2 STK26 POLR2B CHD9 PSMD2 STIP1 ZNF598 ZC3H6 MED12 GSK3A PHLDB2 AXIN1 AXIN2 RAVER1 | 7.35e-06 | 1247 | 95 | 14 | 27684187 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 30060949 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 34534636 | ||
| Pubmed | Ferroxidase hephaestin's cell-autonomous role in the retinal pigment epithelium. | 7.38e-06 | 2 | 95 | 2 | 22342521 | |
| Pubmed | The oral iron chelator deferiprone protects against iron overload-induced retinal degeneration. | 7.38e-06 | 2 | 95 | 2 | 21051716 | |
| Pubmed | Cp/Heph mutant mice have iron-induced neurodegeneration diminished by deferiprone. | 7.38e-06 | 2 | 95 | 2 | 26303407 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29355933 | ||
| Pubmed | Hephaestin and ceruloplasmin facilitate iron metabolism in the mouse kidney. | 7.38e-06 | 2 | 95 | 2 | 27991585 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 11809808 | ||
| Pubmed | Axin2 regulates chondrocyte maturation and axial skeletal development. | 7.38e-06 | 2 | 95 | 2 | 19623616 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 38397122 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 35464477 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 18083923 | ||
| Pubmed | Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. | 7.38e-06 | 2 | 95 | 2 | 15042511 | |
| Pubmed | Ceruloplasmin/hephaestin knockout mice model morphologic and molecular features of AMD. | 7.38e-06 | 2 | 95 | 2 | 18326691 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 25788583 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 33096676 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 15365174 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 27475959 | ||
| Pubmed | Mutations in Lama1 disrupt retinal vascular development and inner limiting membrane formation. | 7.38e-06 | 2 | 95 | 2 | 20048158 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 29883959 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 24720953 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 35977516 | ||
| Pubmed | Functional role of laminin α1 chain during cerebellum development. | 7.38e-06 | 2 | 95 | 2 | 22274713 | |
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 28107521 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 17065470 | ||
| Pubmed | 7.38e-06 | 2 | 95 | 2 | 31263155 | ||
| Pubmed | FBXO22 promotes leukemogenesis by targeting BACH1 in MLL-rearranged acute myeloid leukemia. | 9.16e-06 | 497 | 95 | 9 | 36774506 | |
| Pubmed | RGPD4 RGPD2 RANBP2 RGPD8 CENPF RGPD3 PDE4DIP RGPD1 STIP1 NOP2 PREPL PHLDB2 | 1.26e-05 | 963 | 95 | 12 | 28671696 | |
| Pubmed | Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling. | 1.31e-05 | 17 | 95 | 3 | 17510365 | |
| Pubmed | Hsp90 cochaperone Aha1 downregulation rescues misfolding of CFTR in cystic fibrosis. | 1.65e-05 | 195 | 95 | 6 | 17110338 | |
| Pubmed | 2.12e-05 | 59 | 95 | 4 | 31351040 | ||
| Pubmed | The human cytoplasmic dynein interactome reveals novel activators of motility. | RANBP2 STXBP5 POLR2B RGPD1 CP TAB1 PAN3 FCHO2 ZNF598 GSK3A RAVER1 | 2.17e-05 | 853 | 95 | 11 | 28718761 |
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 33811251 | ||
| Pubmed | 2.21e-05 | 3 | 95 | 2 | 23640881 | ||
| Interaction | RGPD4 interactions | 6.65e-12 | 22 | 95 | 7 | int:RGPD4 | |
| Interaction | RGPD2 interactions | 3.40e-11 | 27 | 95 | 7 | int:RGPD2 | |
| Interaction | RGPD1 interactions | 6.95e-11 | 49 | 95 | 8 | int:RGPD1 | |
| Interaction | RGPD8 interactions | 2.11e-09 | 74 | 95 | 8 | int:RGPD8 | |
| Interaction | RGPD3 interactions | 2.23e-09 | 47 | 95 | 7 | int:RGPD3 | |
| Interaction | RGPD5 interactions | 1.71e-08 | 96 | 95 | 8 | int:RGPD5 | |
| Interaction | NPIPB6 interactions | 1.35e-06 | 18 | 95 | 4 | int:NPIPB6 | |
| Interaction | NOX5 interactions | 3.56e-05 | 14 | 95 | 3 | int:NOX5 | |
| Interaction | SYNE3 interactions | NBAS RANBP2 MLEC DNAJC16 TOR1A PROSER1 PAN3 ZNF598 CDC23 RAVER1 | 4.63e-05 | 444 | 95 | 10 | int:SYNE3 |
| Interaction | RANBP2 interactions | 5.21e-05 | 361 | 95 | 9 | int:RANBP2 | |
| Cytoband | 2q13 | 1.27e-05 | 68 | 95 | 4 | 2q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2q13 | 2.57e-04 | 59 | 95 | 3 | chr2q13 | |
| Cytoband | 2p11.2 | 3.26e-04 | 64 | 95 | 3 | 2p11.2 | |
| Cytoband | 2q12.3 | 5.65e-04 | 17 | 95 | 2 | 2q12.3 | |
| Cytoband | 16q12.2 | 1.33e-03 | 26 | 95 | 2 | 16q12.2 | |
| GeneFamily | Tetratricopeptide repeat domain containing|Bardet-Biedl syndrome associated|BBSome | 7.01e-12 | 115 | 63 | 10 | 769 | |
| Coexpression | GAUSSMANN_MLL_AF4_FUSION_TARGETS_B_UP | 2.41e-11 | 33 | 94 | 7 | MM477 | |
| Coexpression | TABULA_MURIS_SENIS_TRACHEA_GRANULOCYTE_AGEING | 9.91e-09 | 43 | 94 | 6 | MM3857 | |
| Coexpression | GSE17974_0H_VS_48H_IN_VITRO_ACT_CD4_TCELL_UP | 6.06e-06 | 192 | 94 | 7 | M4174 | |
| Coexpression | FOSTER_TOLERANT_MACROPHAGE_DN | 2.69e-05 | 435 | 94 | 9 | MM1221 | |
| Coexpression | GSE4590_LARGE_PRE_BCELL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 3.94e-05 | 174 | 94 | 6 | M6877 | |
| Coexpression | HOUNKPE_HOUSEKEEPING_GENES | RGPD4 RGPD2 RANBP2 HSP90B2P RGPD8 MLEC RGPD3 RGPD1 TOR1A STIP1 TAB1 UTP3 GSK3A CDC23 | 6.40e-05 | 1158 | 94 | 14 | MM1338 |
| Coexpression | GSE360_CTRL_VS_L_DONOVANI_DC_UP | 8.30e-05 | 199 | 94 | 6 | M5143 | |
| Coexpression | GSE32986_GMCSF_VS_GMCSF_AND_CURDLAN_HIGHDOSE_STIM_DC_UP | 8.54e-05 | 200 | 94 | 6 | M8630 | |
| Coexpression | GSE29618_MONOCYTE_VS_MDC_UP | 8.54e-05 | 200 | 94 | 6 | M4948 | |
| Coexpression | GSE12392_WT_VS_IFNB_KO_CD8A_NEG_SPLEEN_DC_DN | 8.54e-05 | 200 | 94 | 6 | M7150 | |
| ToppCell | severe-immature_Neutrophil|severe / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 2.45e-07 | 200 | 95 | 7 | a9b87accdaa6956116ab82427e1330e8f007ef94 | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.14e-06 | 176 | 95 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | BAL-Severe-cDC_0|Severe / Compartment, Disease Groups and Clusters | 4.35e-06 | 199 | 95 | 6 | d39be8b173156bf87baddd3caed4b35597c53ea1 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 152 | 95 | 5 | 0cb5f4dfae04e3f4eba502bbf229007d5fa3884d | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.87e-05 | 152 | 95 | 5 | ba89ffb5a8bb33c188f854f54b39123b6d73496a | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 169 | 95 | 5 | 665b958f4a720ca369a8a0abc7fbe8b6e13c8ce5 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 3.11e-05 | 169 | 95 | 5 | 6614c9851537e4c21b1e45ff0cc3bad07ef9d034 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.20e-05 | 170 | 95 | 5 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|Heart / Disease (COVID-19 only), tissue and cell type | 3.20e-05 | 170 | 95 | 5 | 4232fe937909f93d3736988c707b8f95ce993398 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell|Adult / Lineage, Cell type, age group and donor | 3.47e-05 | 173 | 95 | 5 | a5331721bd9f9a66530dd4ffe28cb3a5a8cad8fc | |
| ToppCell | COVID-19-Heart-CM_3|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.77e-05 | 176 | 95 | 5 | 9df7a124ebafb0087da0cda133a394275d7bed81 | |
| ToppCell | AT1_cells-HP_01|World / lung cells shred on cell class, cell subclass, sample id | 3.77e-05 | 176 | 95 | 5 | 458720776b0151cd55acc352d509599cb62f0ca8 | |
| ToppCell | 10x_3'_v2v3-Non-neoplastic-Myeloid-TAM-MG-TAM-MG_pro-infl_II-C|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.09e-05 | 179 | 95 | 5 | 87f608b137aae34572b150492a83a3a127cff40b | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.31e-05 | 181 | 95 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c01-LEF1|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 4.66e-05 | 184 | 95 | 5 | 5350b58aa9979631228835d11eb45ddf81d08bff | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.78e-05 | 185 | 95 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.78e-05 | 185 | 95 | 5 | 8207f9eff113eed429e961748c6b17d672a13b33 | |
| ToppCell | Influenza-Influenza_Severe-Myeloid-Neutrophil|Influenza_Severe / Disease, condition lineage and cell class | 4.91e-05 | 186 | 95 | 5 | 1dfcec9196d4db76fba3abc74e85885b1fb98b87 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Myeloid / Donor, Lineage, Cell class and subclass (all cells) | 4.91e-05 | 186 | 95 | 5 | 9673367cb53bafb873a01ef6bda11d9f392ce648 | |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 5.03e-05 | 187 | 95 | 5 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.16e-05 | 188 | 95 | 5 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | Pericytes-IPF_03|World / lung cells shred on cell class, cell subclass, sample id | 5.16e-05 | 188 | 95 | 5 | 14c1c88a944c66f2eaac1ce7526815dcce1f5147 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 189 | 95 | 5 | 7fbe855bfdb47d35e040b04a80fe4b729a3764e8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.29e-05 | 189 | 95 | 5 | 06b35abecd29f902cf251fcc1f6ad33db7ab08a2 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 5.29e-05 | 189 | 95 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 5.43e-05 | 190 | 95 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | Children_(3_yrs)-Immune-interstitial_macrophage_(C1Q_positive)|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.43e-05 | 190 | 95 | 5 | f573fef3762a30c38cf8fa7f45df0ffbb49dc873 | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Epithelial-Intermediate_tubule_epithelial_cell-kidney_loop_of_Henle_thin_descending_limb_epithelial_cell-Descending_Thin_Limb_Cell_Type_1|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 5.43e-05 | 190 | 95 | 5 | a5db902ad112a0c0a0a7f1a2e38718bb3bd11412 | |
| ToppCell | PBMC-Severe-Myeloid-Neutrophil-immature_Neutrophil|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 5.56e-05 | 191 | 95 | 5 | 6c1283d51a845cff67ed5e500f7e944165297b53 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 191 | 95 | 5 | 97fb4232417a39801e87725755fd16a57c250209 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 5.56e-05 | 191 | 95 | 5 | 64070a309d7e3f6001272409ab9ce206d0e7d73f | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.84e-05 | 193 | 95 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 5.99e-05 | 194 | 95 | 5 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.99e-05 | 194 | 95 | 5 | 88db9f9e80c20ff3474f1f6459dcbdc25aec0b6d | |
| ToppCell | 390C-Epithelial_cells-Epithelial-I_(AT1)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 5.99e-05 | 194 | 95 | 5 | a71728202493d4858342ea2756ea281cd0d99a3a | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 6.14e-05 | 195 | 95 | 5 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Fibroblasts-Pericytes|Fibroblasts / lung cells shred on cell class, cell subclass, sample id | 6.14e-05 | 195 | 95 | 5 | c2ebc0b33bda9b35b9ef26d69e5d2c6acfdb6ff1 | |
| ToppCell | severe-Myeloid-Immature_Neutrophils_1|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs | 6.14e-05 | 195 | 95 | 5 | becad890a420267ca41e98e61a8da343b51e1945 | |
| ToppCell | 343B-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.14e-05 | 195 | 95 | 5 | 67b05a0cd2ca9924eca81a92cc6330eecb9d963c | |
| ToppCell | Secretory|World / shred by cell class for bronchial biopsy | 6.14e-05 | 195 | 95 | 5 | 52f8281fe0df67cec3faa780a23ed6343ed5a6ba | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-bronchial_goblet_cell-Goblet_(bronchial)-Goblet_(bronchial)_L.0.4.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 6.29e-05 | 196 | 95 | 5 | 2c3fbfbb08cd327cd97b3fa5a6f83b6d50771fb7 | |
| ToppCell | 367C-Myeloid-Macrophage-M2-like_Macrophage_(MARCO_negative)|Macrophage / Donor, Lineage, Cell class and subclass (all cells) | 6.29e-05 | 196 | 95 | 5 | e8c4eeb4b6c6d9bccca2adb942d4cfbaab39636c | |
| ToppCell | COVID-19-Heart-Mito_CM|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.44e-05 | 197 | 95 | 5 | 44e49943d62bfe622b40ad0460093d31540544df | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.44e-05 | 197 | 95 | 5 | e77c91f5a1f5a292eda41abf3b1e31180f2c61e1 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.44e-05 | 197 | 95 | 5 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | distal-3-Hematologic-IGSF21+_Dendritic|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.44e-05 | 197 | 95 | 5 | 52e9dc35dd8cc2605fa4894bb16bb5c6086faa76 | |
| ToppCell | Bronchial-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 95 | 5 | f261a37dd07976548b897af86df1d1a0dc069889 | |
| ToppCell | distal-Hematologic-IGSF21+_Dendritic-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 6.60e-05 | 198 | 95 | 5 | 323b4e6c31e18227546bb30566c1d872fda45e36 | |
| ToppCell | 10x3'2.3-week_17-19-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.60e-05 | 198 | 95 | 5 | 3bc05b8d97a7219af40db7a11aa271f02e74fca5 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 95 | 5 | c12e7511628db819a52959bb68580e27c00c2e41 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_airway_ASM|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.60e-05 | 198 | 95 | 5 | 22e766df1276c5b14aa0d83f434f47140ebb98ea | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.75e-05 | 199 | 95 | 5 | 980b10b81ee9dc952e3be25bd294201ce5a4ca8b | |
| ToppCell | 10x5'v1-week_14-16-Myeloid_neutrophil-granulo-neutrophil-myelocyte|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 6.75e-05 | 199 | 95 | 5 | a1635a52318be0423f8e4fc03d971c28cd22b57e | |
| ToppCell | NS-control-d_0-4-Epithelial-Secretory|d_0-4 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined) | 6.75e-05 | 199 | 95 | 5 | 32bdfff40fd442b88489c8b0f79af3927a51a03c | |
| ToppCell | 10x5'v1-week_17-19-Myeloid_macrophage-stroma|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 6.75e-05 | 199 | 95 | 5 | cbd423c31d75f6d2f5ae85d2241641fcbe630b81 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil|COVID-19_Severe / Disease condition and Cell class | 6.75e-05 | 199 | 95 | 5 | f82fa9d651e78f9ebbe6264e00a48c54b1786a69 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 6.75e-05 | 199 | 95 | 5 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | COVID-19_Severe-immature_Neutrophil-|COVID-19_Severe / Disease condition and Cell class | 6.75e-05 | 199 | 95 | 5 | 42ea0c19c455bdb0ae89b428d09c333104c670dc | |
| ToppCell | control-Epithelial-Secretory|Epithelial / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.75e-05 | 199 | 95 | 5 | 3d01f90ffd271ca00129192787e4921bdca7e01e | |
| ToppCell | control-Epithelial-Secretory|control / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 6.75e-05 | 199 | 95 | 5 | 262e5b8a52c8ddb0b47048c786e8bdb7158e1b9a | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | COVID-19-COVID-19_Severe-Myeloid-immature_Neutrophil|COVID-19_Severe / Disease, condition lineage and cell class | 6.92e-05 | 200 | 95 | 5 | cbe667eda1af222467df8bfa157aa22df488f133 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP----L1-3|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.92e-05 | 200 | 95 | 5 | a20dce14f94777687aad57d6fbe3258ad376f63f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP--|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.92e-05 | 200 | 95 | 5 | dc344b3ec51d506952e38f0b3a7795d65f9dd4eb | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 6.92e-05 | 200 | 95 | 5 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP-|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.92e-05 | 200 | 95 | 5 | 3bba5219453322198e8fdb0921d5f8c403598751 | |
| ToppCell | Hematolymphoid-Microglia|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.92e-05 | 200 | 95 | 5 | 21bcca3b670fe9bac034aef2275d3de4a9a73e2b | |
| ToppCell | LPS_only-Mesenchymal_myocytic-Pericyte|LPS_only / Treatment groups by lineage, cell group, cell type | 6.92e-05 | 200 | 95 | 5 | 8c8ef2b19ab5b1bfc0fae6c38a330f464f28e86f | |
| ToppCell | Hematolymphoid-Microglia-TYROBP---|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.92e-05 | 200 | 95 | 5 | a8646d0fca99f10827c2d2a12e584660ef7155f1 | |
| ToppCell | Hematolymphoid-Microglia-TYROBP|Hematolymphoid / cells hierarchy compared to all cells using T-Statistic | 6.92e-05 | 200 | 95 | 5 | 33036d21c1c82109284473a515c4f890b33fdd5c | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 2.05e-04 | 136 | 95 | 4 | 7cd22169fb71c6caf9feb203ad98be8480a54fba | |
| ToppCell | renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group | 2.91e-04 | 149 | 95 | 4 | 61d84838a841ed2d6b8c5f86d423a4e6b3dcc9cb | |
| ToppCell | saliva-Mild-Moderate_progression_d12-25-Myeloid-Granulocytic-Neutrophil-Neu_c6-FGF23|Mild-Moderate_progression_d12-25 / Compartment, severity and other cell annotations on 10x 3' data (130k) | 3.14e-04 | 152 | 95 | 4 | 0652ee3443e6fbb679d2c4f326239ae7c803f924 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells) | 3.14e-04 | 152 | 95 | 4 | ca23261d8ef263cc697b8d7e7cb2afec8bc564f2 | |
| ToppCell | Severe-B_naive-5|World / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.22e-04 | 153 | 95 | 4 | 44572f87d403e314050ab935d2cd676c33d9c287 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 157 | 95 | 4 | 8d30d8e6fae93afcada6bd68799439335cd65b69 | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 157 | 95 | 4 | 2ac4695d9e4ca8d4ba19c555e9a1d86ac8f398ab | |
| ToppCell | facs-Heart-Unknown-3m-Myeloid-monocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-04 | 157 | 95 | 4 | 8a393eece90fb9a1b7c356736bdb36277261fbd3 | |
| ToppCell | Severe-B_naive-5|Severe / disease group and sub_cluster of B and Plasma cells(res = 0.5) | 3.55e-04 | 157 | 95 | 4 | a57ee4a6febdff3ee3d1645836695e6e7c055cf8 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.64e-04 | 158 | 95 | 4 | 08806240228c5b780f5aef92ce2c278ae4d797cc | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC-SMC_Acta2|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.64e-04 | 158 | 95 | 4 | 496b6988f7b3439968351840ae22f56ffa1643f1 | |
| ToppCell | frontal_cortex-Non-neuronal-smooth_muscle_cell-SMC|frontal_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype | 3.64e-04 | 158 | 95 | 4 | 5b3d30f92b619f14a7b48502170000fa5783358a | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 158 | 95 | 4 | 2a222301474c4dfd9a776e197c10f4c1cacceb62 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 158 | 95 | 4 | ff9878fd768f22bf2ee4805bac2ba01cb3cb804a | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 158 | 95 | 4 | d43b335e6aa12d84a75b988fbd6127ff1f4af25c | |
| ToppCell | facs-Lung-ENDOMUCIN-18m-Myeloid-Neutrophil|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.64e-04 | 158 | 95 | 4 | ab12b29ce51ca2fcac469cc932391217d97145f9 | |
| ToppCell | 368C-Lymphocytic-CD4_T-cell-CD4+_Naive_T_cell_/_CD4+_Trm_cell|CD4_T-cell / Donor, Lineage, Cell class and subclass (all cells) | 3.81e-04 | 160 | 95 | 4 | 19105debef96ea0c267d6a1d332303ec668ae47e | |
| ToppCell | 3'-Distal_airway-Immune_Myeloid-Myeloid_monocytic-non-classical_monocyte-Non-classical_monocytes-Non-classical_monocytes_L.1.2.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.81e-04 | 160 | 95 | 4 | 709ce00699ca05346287868ea55a1affae0859a8 | |
| ToppCell | Adult-Mesenchymal-airway_smooth_muscle_cell-D231|Adult / Lineage, Cell type, age group and donor | 3.81e-04 | 160 | 95 | 4 | d783d29150033e9181c0e30870070268fed3fd85 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.90e-04 | 161 | 95 | 4 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | Influenza_Severe-Neutrophil|Influenza_Severe / Disease group and Cell class | 3.90e-04 | 161 | 95 | 4 | 98c95b1b85d5427415af2ca8fb14849e97f6e8b5 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell-Renin-positive_Juxtaglomerular_Granular_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-04 | 162 | 95 | 4 | c7114e24cb5525abb9780ca3d35dbcc4eabd4b64 | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal--glomerular_mesenchymal_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-04 | 162 | 95 | 4 | f1851a173d3bcca2981d934161ec85d1cc0af5a2 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 162 | 95 | 4 | 3a61eda548afa2a41bdf6293d1050103dc210e52 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.00e-04 | 162 | 95 | 4 | 593939be9d38690c89c31d4c58e351de26cbf9ab | |
| ToppCell | kidney_cells-Adult_normal_reference-Mesenchymal-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 4.00e-04 | 162 | 95 | 4 | 5d902bb31e691aea9749617cc88303c2448f24b8 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-04 | 163 | 95 | 4 | 360cd65decda24853124f33a174f5224d7f3ce23 | |
| ToppCell | LPS-IL1RA+antiTNF-Epithelial_alveolar-Mes-like-AT1_Progenitor|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 4.09e-04 | 163 | 95 | 4 | b59d9b4f7c9f4e5e2c7783a49a96729dae3a81e5 | |
| ToppCell | 367C-Myeloid-Dendritic-cDC_proliferating_2|367C / Donor, Lineage, Cell class and subclass (all cells) | 4.19e-04 | 164 | 95 | 4 | 0662cd9d21608efacc336e0a582859f3b9a4951d | |
| ToppCell | droplet-Limb_Muscle-nan-3m-Myeloid-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.38e-04 | 166 | 95 | 4 | 0a7992bc673fca546636563ec3fc17a4298ab6b1 | |
| Disease | venous thromboembolism, von Willebrand factor measurement | 7.93e-06 | 42 | 89 | 4 | EFO_0004286, EFO_0004629 | |
| Disease | Paroxysmal atrial fibrillation | 8.02e-06 | 156 | 89 | 6 | C0235480 | |
| Disease | familial atrial fibrillation | 8.02e-06 | 156 | 89 | 6 | C3468561 | |
| Disease | Persistent atrial fibrillation | 8.02e-06 | 156 | 89 | 6 | C2585653 | |
| Disease | Atrial Fibrillation | 9.27e-06 | 160 | 89 | 6 | C0004238 | |
| Disease | factor VIII measurement, von Willebrand factor measurement | 7.36e-05 | 27 | 89 | 3 | EFO_0004629, EFO_0004630 | |
| Disease | Ischemic stroke, von Willebrand factor measurement | 1.02e-04 | 30 | 89 | 3 | EFO_0004629, HP_0002140 | |
| Disease | factor VIII measurement, venous thromboembolism | 1.48e-04 | 34 | 89 | 3 | EFO_0004286, EFO_0004630 | |
| Disease | factor VIII measurement | 2.42e-04 | 40 | 89 | 3 | EFO_0004630 | |
| Disease | Depressive disorder | 2.47e-04 | 289 | 89 | 6 | C0011581 | |
| Disease | Recurrent depression | 3.19e-04 | 9 | 89 | 2 | C0221480 | |
| Disease | fibrinogen measurement, tissue plasminogen activator measurement | 3.43e-04 | 45 | 89 | 3 | EFO_0004623, EFO_0004791 | |
| Disease | colorectal cancer (is_implicated_in) | 5.02e-04 | 121 | 89 | 4 | DOID:9256 (is_implicated_in) | |
| Disease | myeloid white cell count | FAP PDE3A HSP90B2P GNPDA1 PTPRJ STXBP5 PSMD2 CD46 NLRP3 SORL1 | 5.24e-04 | 937 | 89 | 10 | EFO_0007988 |
| Disease | Pulmonary Thromboembolisms | 5.82e-04 | 12 | 89 | 2 | C0524702 | |
| Disease | Pulmonary Embolism | 5.82e-04 | 12 | 89 | 2 | C0034065 | |
| Disease | neutrophil count, basophil count | 5.96e-04 | 224 | 89 | 5 | EFO_0004833, EFO_0005090 | |
| Disease | von Willebrand factor measurement | 6.55e-04 | 56 | 89 | 3 | EFO_0004629 | |
| Disease | alcohol and nicotine codependence | 6.87e-04 | 13 | 89 | 2 | EFO_0004776 | |
| Disease | creatine kinase measurement | 7.63e-04 | 59 | 89 | 3 | EFO_0004534 | |
| Disease | creatinine measurement | 8.31e-04 | 995 | 89 | 10 | EFO_0004518 | |
| Disease | atrial fibrillation | 9.17e-04 | 371 | 89 | 6 | EFO_0000275 | |
| Disease | alkaline phosphatase measurement | PTPRJ SLC26A4 PYGL ST6GAL1 TAB1 FCHO2 PLEKHD1 NLRP3 GABBR1 AXIN1 | 9.66e-04 | 1015 | 89 | 10 | EFO_0004533 |
| Disease | hemorrhoid | 1.04e-03 | 147 | 89 | 4 | EFO_0009552 | |
| Disease | granulocyte count | 1.05e-03 | 254 | 89 | 5 | EFO_0007987 | |
| Disease | acute lymphoblastic leukemia | 1.06e-03 | 66 | 89 | 3 | EFO_0000220 | |
| Disease | venous thromboembolism, fibrinogen measurement | 1.11e-03 | 67 | 89 | 3 | EFO_0004286, EFO_0004623 | |
| Disease | SLAM family member 7 measurement | 1.19e-03 | 17 | 89 | 2 | EFO_0008287 | |
| Disease | Congenital Myasthenic Syndromes, Postsynaptic | 1.19e-03 | 17 | 89 | 2 | C0751883 | |
| Disease | Colorectal Carcinoma | 1.28e-03 | 702 | 89 | 8 | C0009402 | |
| Disease | Malignant tumor of colon | 1.39e-03 | 159 | 89 | 4 | C0007102 | |
| Disease | factor VIII measurement, Ischemic stroke | 1.49e-03 | 19 | 89 | 2 | EFO_0004630, HP_0002140 | |
| Disease | N-glycan measurement | 2.00e-03 | 22 | 89 | 2 | EFO_0004999 | |
| Disease | Immunologic Deficiency Syndromes | 2.18e-03 | 23 | 89 | 2 | C0021051 | |
| Disease | Colorectal cancer | 3.01e-03 | 27 | 89 | 2 | cv:C0346629 | |
| Disease | Glycogen Storage Disease | 3.01e-03 | 27 | 89 | 2 | C0017919 | |
| Disease | COLORECTAL CANCER | 3.01e-03 | 27 | 89 | 2 | 114500 | |
| Disease | Neoplasm of the large intestine | 3.01e-03 | 27 | 89 | 2 | cv:C0009404 | |
| Disease | indole-3-propionate measurement | 3.01e-03 | 27 | 89 | 2 | EFO_0010501 | |
| Disease | hypertension, COVID-19 | 3.01e-03 | 27 | 89 | 2 | EFO_0000537, MONDO_0100096 | |
| Disease | thrombocytopenia (is_implicated_in) | 3.01e-03 | 27 | 89 | 2 | DOID:1588 (is_implicated_in) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| NVKCAYKKYLYGFEE | 381 | Q4LE39 | |
| KAYLEEEEYLGKKSY | 161 | Q5W0A0 | |
| AYTLAKAYFDVKEYD | 86 | Q9UJX2 | |
| TYKLYVEKYALAKAD | 176 | Q0JRZ9 | |
| AYYTVYKKSLGDDIS | 131 | P12429 | |
| FKKHYGYSLYSAIKS | 291 | P12429 | |
| FKEQLSKKGNYRYYF | 791 | Q9Y2T1 | |
| DYELKYCFVDKYKGT | 81 | Q8IY67 | |
| SMKGFYFAKLYYEAK | 26 | P49792 | |
| SMKGFYFAKLYYEAK | 26 | Q99666 | |
| SMKGFYFAKLYYEAK | 26 | O14715 | |
| KAVKAFLDYAYTGKT | 101 | Q8NAB2 | |
| GFLKAYVEKFSYKSI | 406 | P09960 | |
| GEFYIGSKYKKVVYR | 771 | P00450 | |
| DEYGSKKSDYIKLYV | 56 | Q58FF3 | |
| AFGELKDYYLFYLKS | 396 | P42898 | |
| YEDFKKGASDTYVTY | 871 | Q12913 | |
| IGERVDYKCKKGYFY | 56 | P15529 | |
| KLIEYYKNGDLSFKY | 51 | P46926 | |
| DFGLSKKIYSGDYYR | 741 | Q12866 | |
| TFTGKLYIEFVKGYY | 186 | Q14165 | |
| SYKKIGYYDSTKDDL | 546 | Q9UBS5 | |
| GYFKDKAFVNYLKYL | 41 | Q9Y3C7 | |
| KGKIYSLNEGYAKYF | 206 | O00757 | |
| CDEFTKSYYKSKYGI | 356 | Q5JST6 | |
| KSYYKSKYGIENFTS | 361 | Q5JST6 | |
| YVFSKTYNVTDDKYG | 801 | Q14432 | |
| LYKLTAFAYKDYLSF | 286 | Q9Y2G8 | |
| FSKKEEVFGYLAKYT | 136 | Q93074 | |
| DYEISAKARYFGYIK | 476 | A2RRP1 | |
| YKLKAIEYVHGYFSS | 21 | Q86XN7 | |
| VYYDAIKYKGEKDGA | 741 | Q9BX63 | |
| AVGVKLKYCRYYAKD | 41 | Q58A45 | |
| STRGFYFAKLYYEAK | 26 | A6NKT7 | |
| SYKGIFQYDYHDKVK | 236 | Q9P2Q2 | |
| EYIKSYKIAYSNDGK | 241 | O43854 | |
| YADYKYFVSLFEDKT | 126 | Q96EW2 | |
| IDTEEFFVKYKNYSY | 711 | Q3L8U1 | |
| RYFFYSSGEKKDELY | 176 | P49840 | |
| YLDKGVVTYKFKYEG | 401 | O95393 | |
| SQYYSGSKYEDLKEK | 156 | P49454 | |
| KKGSYRYYFKKVSDE | 816 | O15169 | |
| AVSKKYFEYLGSYDT | 316 | Q8IXK2 | |
| VVYDFGDAKKTASYY | 221 | Q8WWU7 | |
| KLIGFFKSEDSEYYK | 166 | O14958 | |
| KSTDYGKYEGLTKNY | 396 | Q9NV70 | |
| QRKKLYYDTDYGSKS | 131 | Q9NQZ2 | |
| KYEFILKEYESYSDF | 226 | P07358 | |
| KEYDLAKKYVCTYLS | 31 | P0DJD0 | |
| LGFSEAKRKEYFFKY | 371 | Q96P20 | |
| AKRKEYFFKYFSDEA | 376 | Q96P20 | |
| KYREKIYYFSSAEAK | 956 | Q5TCS8 | |
| KYSKYKFTPAAEFYE | 201 | P23975 | |
| STRGFYFAKLYYEAK | 26 | Q7Z3J3 | |
| YVSYDYGKSFKKISD | 136 | Q92673 | |
| AAYAKKGDYQKAYED | 46 | P31948 | |
| YKVKYGYTDIDLLSA | 246 | Q15750 | |
| DFSYAGLKDKKAITY | 331 | Q9H0K6 | |
| LRGFYFAKLYYEAKE | 26 | P0DJD1 | |
| YEAKEYDLAKKYVCT | 36 | P0DJD1 | |
| YVTKYYGSYLKGSKL | 81 | Q9P289 | |
| KYLYSSEDYIKSGAL | 431 | Q13200 | |
| YYKKVADYIADTFEK | 241 | Q5TEA6 | |
| MAYGGKLKYSVAFYS | 1231 | P25391 | |
| GTYKKTIYKEYKDDS | 71 | Q9BQS7 | |
| EEDFRKYFYYLEGSK | 296 | Q15858 | |
| YVFAKKDSKYAYTGE | 206 | P30876 | |
| KGSYYDSFKLQTKEF | 31 | P15907 | |
| GLYYDKAASVYIRSK | 866 | Q8NEZ3 | |
| TLYPAYYSYKAVKSK | 16 | Q9H902 | |
| VYYSIGALAKAVYEK | 421 | P13533 | |
| KKDLAIYYSYGDFLL | 271 | P46087 | |
| YYADKHETKLKGVIY | 1176 | Q86SQ0 | |
| KSKKADYRYTYDEAI | 226 | Q5T5C0 | |
| KYDYVLTGYTRDKSF | 76 | O00764 | |
| TFYDYSYLQGSKLKL | 1466 | Q13023 | |
| YKEGTYVYKTQSEKY | 171 | P58418 | |
| SEKKSYFSYFFGEKS | 301 | Q7RTR0 | |
| YFSYFFGEKSKALKV | 306 | Q7RTR0 | |
| AISYYKIFSDKDGYK | 361 | Q12884 | |
| EDYAAYKESTYAKGK | 301 | P0CB48 | |
| KFKSKEYDEYSTYSD | 131 | P61129 | |
| GYKSVDEYKVHKGSY | 116 | A8MTY0 | |
| YKKAVYITGKEVFSF | 1111 | Q96RL7 | |
| DKGCKTVFTKLDYYY | 316 | O14656 | |
| EGYYYNSSTCKKGKV | 201 | Q9H3R2 | |
| SVGKVYATKYDYTID | 366 | O43511 | |
| YYSESEKKSFETNKY | 61 | A6NEE1 | |
| DEKKGTVYIYSYFHF | 381 | Q86VE9 | |
| KYYTYKFAEGKLFEE | 416 | Q4J6C6 | |
| KKYDIYFADGKVYAL | 96 | Q86UK7 | |
| DKFYKSEDYGKDYPS | 886 | Q9UJU3 | |
| TGFSYYAATKTKYRK | 646 | Q49AG3 | |
| YTFEKSYEFKDFEKA | 611 | Q6PG37 | |
| ALDKKGYEAKEYYEA | 721 | P06737 | |
| TYKDEGNDYFKEKDY | 81 | O95801 | |
| GSGTYATVYKAYAKK | 21 | Q6PHR2 | |
| YSYAAYSAKGTLKAE | 261 | Q58DX5 | |
| YEALYGNSKKGLKAY | 2016 | Q5VU43 | |
| DREYKKGYEASKTKY | 1611 | P20929 | |
| SRDIASDYKYKKAYE | 1811 | P20929 | |
| DIASDYKYKEGYRKQ | 3516 | P20929 |